Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Chicago, Illinois 60611


Purpose:

Can Intraoperative systemic lidocaine decrease postoperative opioid consumption and improve quality of recovery after laparoscopic gastric bypass surgery? The hypotheses:does the use of intraoperative systemic lidocaine decrease postoperative opioid consumption and improve quality of recovery after laparoscopic gastric bypass surgery. This study has the potential to confirm an opioid sparing strategy for morbid obese patients undergoing laparoscopic gastric bypass surgery. The high incidence of obstructive sleep apnea and the increased risk of postoperative hypoxemia make the development of opioid sparing techniques in this patient population warranted.


Criteria:

Inclusion Criteria: - ASA I, II,III; - BMI > 35 kg/m2, - Age between 18-70, - Fluent in English, - Patients undergoing laparoscopic gastric bypass, - EKG within 3 months. Exclusion Criteria: - History of allergy to local anesthetics, - History of chronic opioid use, - Pregnant patients, - History of EKG abnormalities. Dropout: Conversion to open, patient or surgeon request.


NCT ID:

NCT01180660


Primary Contact:

Principal Investigator
Gildasio De Oliveira, M.D
Northwestern University


Backup Contact:

N/A


Location Contact:

Chicago, Illinois 60611
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.